How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Poly(D,L-lactide-co- glycolide) (PLGA) Market
- By Product Type: PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 65:35, PLGA 90:10
- By Molecular Weight: Low Molecular Weight (10,000-30,000 Da), Medium Molecular Weight (30,000-70,000 Da), High Molecular Weight (70,000-150,000 Da)
- By End Group: Acid-terminated PLGA, Ester-terminated PLGA
- By Application: Drug Delivery Systems, Tissue Engineering, Orthopedic Devices, Surgical Sutures, Implants
- By Form: Microspheres, Nanoparticles, Films, Fibers, Hydrogels
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - PLGA 50:50 leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Poly(D,L-lactide-co- glycolide) (PLGA) Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Molecular Weight 3
End Group 2
Application 5
Form 5
Companies profiled
Evonik Industries AG
Corbion N.V.
BASF SE
Shandong Freda Biopharm Co. Ltd.
Jinan Daigang Biomaterial Co. Ltd.
Polyscitech (Akina
Inc.)
Lactel Absorbable Polymers
Mitsubishi Chemical Corporation
Boehringer Ingelheim GmbH
Wuhan Yuancheng Gongchuang Technology Co. Ltd.
Hangzhou Ruixiang Biotechnology Co. Ltd.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Evonik Industries AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Corbion N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Shandong Freda Biopharm Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Jinan Daigang Biomaterial Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Polyscitech (Akina
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Inc.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Lactel Absorbable Polymers
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Mitsubishi Chemical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Boehringer Ingelheim GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Wuhan Yuancheng Gongchuang Technology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Hangzhou Ruixiang Biotechnology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Jiangsu Suqing Biomaterials Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Evonik Nutrition & Care GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Shenzhen Esun Industrial Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Evonik Health Care GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,219M by 2033 · 9.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- PLGA 50:5042.2
- PLGA 75:2516.8
- PLGA 85:1513.9
- PLGA 65:3512.4
- PLGA 90:1014.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,028M → $2,242M · 10.2%
Europe$716.1M → $1,481M · 9.5%
Asia Pacific$653.9M → $1,459M · 10.6%
Latin America$404.8M → $811.2M · 9.1%
Middle East and Africa$311.4M → $608.5M · 8.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.972026
9.012027
9.002028
9.022029
9.042030
9.052031
9.052032
9.062033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Evonik Industries AG18.2
- Corbion N.V.9.9
- BASF SE14.4
- Shandong Freda Biopharm Co. Ltd.7.0
- Jinan Daigang Biomaterial Co. Ltd.13.7
- Polyscitech (Akina8.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type19.2%
Molecular Weight18.2%
End Group20.1%
Application21.0%
Form21.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.0
- Europe22.4
- Asia Pacific22.1
- Latin America12.3
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Evonik Industries AG | 76 | 97 | 90 | 86 | 94 | 94 | 90 |
| Corbion N.V. | 86 | 79 | 68 | 70 | 70 | 73 | 74 |
| BASF SE | 81 | 78 | 75 | 72 | 83 | 79 | 78 |
| Shandong Freda Biopharm Co. Ltd. | 81 | 64 | 66 | 58 | 60 | 82 | 69 |
| Jinan Daigang Biomaterial Co. Ltd. | 69 | 69 | 65 | 71 | 63 | 61 | 66 |
| Polyscitech (Akina | 69 | 71 | 46 | 61 | 54 | 51 | 59 |
| Inc.) | 48 | 44 | 51 | 60 | 47 | 42 | 49 |
| Lactel Absorbable Polymers | 60 | 36 | 58 | 39 | 56 | 58 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Evonik Industries AG
- Corbion N.V.
- BASF SE
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Evonik Industries AG | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Corbion N.V. | ◐ | ◐ | − | ✓ | ◐ | − |
| BASF SE | ◐ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Shandong Freda Biopharm Co. Ltd. | ◐ | ✓ | ◐ | ◐ | ◐ | ✓ |
| Jinan Daigang Biomaterial Co. Ltd. | − | ◐ | ◐ | ◐ | − | − |
| Polyscitech (Akina | ✓ | ◐ | − | ◐ | ◐ | − |
| Inc.) | − | − | − | ◐ | − | − |
| Lactel Absorbable Polymers | ◐ | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Evonik Industries AG90
2BASF SE78
3Corbion N.V.74
4Shandong Freda Biopharm Co. Ltd.69
5Jinan Daigang Biomaterial Co. Ltd.66
6Polyscitech (Akina59
7Lactel Absorbable Polymers51
8Inc.)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Evonik Industries AGBASF SE
Challenger2
Strong scale, closing on the leaders.
Corbion N.V.Shandong Freda Biopharm Co. Ltd.
Contender2
Focused players with pockets of strength.
Jinan Daigang Biomaterial Co. Ltd.Polyscitech (Akina
Niche2
Specialists in a single segment or region.
Inc.)Lactel Absorbable Polymers
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Poly(D,L-lactide-co- glycolide) (PLGA) Market — a $170M beachhead inside a $3.14B market.
Beachhead (SOM)$170Mobtainable near-term
Serviceable (SAM)$1.20Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
PLGA 50:50
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
PLGA 75:25
Strong fit — clear ROI and a fast path to value.
End user65 fit
PLGA 85:15
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Molecular Weight & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End Group
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Poly(D,L-lactide-co- glycolide) (PLGA) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified26%
Evaluation14%
Closed-won6%
$17.4KCAC
$97KLTV
5.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Poly(D,L-lactide-co- glycolide) (PLGA) Market is a durable-growth opportunity — $9.67B by 2033, compounding at 8.9%.
TAM · 2025$4.89Btoday
TAM · 2033$9.67Bforecast
CAGR8.9%2027–2033
Cumulative$63.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.67BTotal addressable market
SAM$3.77BServiceable available market
SOM$786MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.67BLarge & growingTAM by 2033 at 8.9% CAGR
$3.77BServiceable nowreachable with today’s model
$786MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.54BBear5.8% CAGR
$9.67BBase8.9% CAGR
$12.4BBull11.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Molecular Weight optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Poly(D,L-lactide-co- glycolide) (PLGA) Market — a $6.27B market by 2033. Plan: grow share from 7.0% to 13.7%.
Market size · 2033$6.27Btotal addressable
Market CAGR7.3%2027–2033
Target share13.7%from 7.0% today
Revenue ambition$859Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.0% | 13.7% | On track |
| Revenue | $425M | $859M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 36.4% | 38.6% | On track |
| Customer retention | 84.5% | 92.1% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Molecular Weight capability
A defensible second engine — invest in Molecular Weight to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Molecular Weight
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $102M capacity & capability investment
- Greenlight bolt-on M&A in Molecular Weight
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Poly(D,L-lactide-co- glycolide) (PLGA) Market conversation — a $2.07B market you can size, segment and defend in minutes.
Market size · 2033$2.07Btotal opportunity
Growth10.1%CAGR to 2033
Addressable buyers1,654+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 4 mopayback period
$82K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Evonik Industries AGCorbion N.V.BASF SEShandong Freda Biopharm Co. Ltd.Jinan Daigang Biomaterial Co. Ltd.Polyscitech (AkinaInc.)Lactel Absorbable Polymers+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Poly(D,L-lactide-co- glycolide) (PLGA) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Poly(D,L-lactide-co- glycolide) (PLGA) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Polydioxanone Threads (PDO Threads) Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportPolydioxanone Monofilament Suture Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportPolydioxanone Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportPolydeoxyribonudeotide (PDRN) Market
Polydeoxyribonudeotide (PDRN) Market is valued at USD 185 Million in 2025 and is expected to re…
$185M market · 2025 base year
View reportPolycythemia Vera Treatment Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportPolycythemia Vera Treatment Drugs Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportPolycystic Kidney Disease Treatment Drugs Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportPolyclonal Rabbit Anti-Mouse Immunoglobulins Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportPolycarboxylate Dental Adhesives Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportPolycarbophil Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportPolycarbonate for Medical Use Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportPolycarbonate for Medical Device Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.